TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
55 hedge funds and large institutions have $44.9M invested in Tvardi Therapeutics, Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 11 increasing their positions, 18 reducing their positions, and 4 closing their positions.
Holders
55
Holders Change
+20
Holders Change %
+57.14%
% of All Funds
0.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
11
Reduced
18
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
SPC
1
Slate Path Capital
New York
|
$16.4M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$9.29M |
3 |
3
BlackRock
New York
|
$6.25M |
4 |
6CM
4
683 Capital Management
New York
|
$3.63M |
5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$2.62M |